Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Rheumatoid Arthritis

  Free Subscription


15.07.2019

1 Ann Rheum Dis
4 Arthritis Res Ther
1 Clin Exp Rheumatol
3 Clin Rheumatol
1 Intern Med
1 PLoS One
2 Rheumatol Int
1 Z Rheumatol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Rheum Dis

  1. LAI SW, Kuo YH, Liao KF
    Association between proton pump inhibitors therapy and fracture risk in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2019 Jul 12. pii: annrheumdis-2019-215982.
    PubMed     Text format    


    Arthritis Res Ther

  2. PENG A, Lu X, Huang J, He M, et al
    Rheumatoid arthritis synovial fibroblasts promote TREM-1 expression in monocytes via COX-2/PGE2 pathway.
    Arthritis Res Ther. 2019;21:169.
    PubMed     Text format     Abstract available

  3. TANAKA Y, Smolen JS, Jones H, Szumski A, et al
    The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis.
    Arthritis Res Ther. 2019;21:164.
    PubMed     Text format     Abstract available

  4. TERSLEV L, Christensen R, Aga AB, Sexton J, et al
    Assessing synovitis in the hands in patients with rheumatoid arthritis by ultrasound: an agreement study exploring the most inflammatory active side from two Norwegian trials.
    Arthritis Res Ther. 2019;21:166.
    PubMed     Text format     Abstract available

  5. EUSTACE AD, McNaughton EF, King S, Kehoe O, et al
    Soluble syndecan-3 binds chemokines, reduces leukocyte migration in vitro and ameliorates disease severity in models of rheumatoid arthritis.
    Arthritis Res Ther. 2019;21:172.
    PubMed     Text format     Abstract available


    Clin Exp Rheumatol

  6. REICHERT S, Jurianz E, Natalie P, Schlumberger W, et al
    Is periodontitis a prognostic factor in order to indicate antibodies against citrullinated peptides in patients with rheumatoid arthritis?
    Clin Exp Rheumatol. 2019 Jun 19. pii: 13892.
    PubMed     Text format     Abstract available


    Clin Rheumatol

  7. SUN W, Tian L, Jiang L, Zhang S, et al
    Sclerostin rather than Dickkopf-1 is associated with mSASSS but not with disease activity score in patients with ankylosing spondylitis.
    Clin Rheumatol. 2019;38:989-995.
    PubMed     Text format     Abstract available

  8. KANG JH, Xirasagar S, Lin HC, Kao PF, et al
    Correction to: Risk of adverse outcomes in patients with rheumatoid arthritis hospitalized for stroke-a cross-sectional study.
    Clin Rheumatol. 2019;38:1533.
    PubMed     Text format     Abstract available

  9. ALTEN R, Feist E, Lorenz HM, Nusslein H, et al
    Abatacept retention and clinical outcomes in rheumatoid arthritis: real-world data from the German cohort of the ACTION study and a comparison with other participating countries.
    Clin Rheumatol. 2019 Jul 12. pii: 10.1007/s10067-019-04648.
    PubMed     Text format     Abstract available


    Intern Med

  10. SAKAGUCHI R, Fujikawa K, Okamoto M, Matsuo E, et al
    A Case of Rheumatoid Arthritis Complicated with Nasal Septum Perforation Due to Methotrexate-associated Lymphoproliferative Disorder.
    Intern Med. 2019 Jul 10. doi: 10.2169/internalmedicine.2995.
    PubMed     Text format     Abstract available


    PLoS One

  11. SASAKI C, Hiraishi T, Oku T, Okuma K, et al
    Metabolomic approach to the exploration of biomarkers associated with disease activity in rheumatoid arthritis.
    PLoS One. 2019;14:e0219400.
    PubMed     Text format     Abstract available


    Rheumatol Int

  12. POPOVA V, Vazhev Z, Geneva-Popova M, Batalov A, et al
    Comparison of RANKL expression, inflammatory markers, and cardiovascular risk in patients with acute coronary syndrome with and without rheumatoid arthritis.
    Rheumatol Int. 2019 Jul 11. pii: 10.1007/s00296-019-04367.
    PubMed     Text format     Abstract available

  13. LILA AM, Mazurov VI, Denisov LN, Nesmeyanova OB, et al
    A phase III study of BCD-055 compared with innovator infliximab in patients with active rheumatoid arthritis: 54-week results from the LIRA study.
    Rheumatol Int. 2019 Jul 10. pii: 10.1007/s00296-019-04359.
    PubMed     Text format     Abstract available


    Z Rheumatol

  14. FIEHN C, Kruger K
    [Treatment algorithm for rheumatoid arthritis : According to the S2e guidelines 2018].
    Z Rheumatol. 2019 Jul 11. pii: 10.1007/s00393-019-0668.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: